In addition, two peptides co-localized with somatostatin, neuropeptide Y and cortistatin, are both significantly down-regulated in MDD patients (Tripp et al., 2011, 2012).These three neuropeptides (somatostatin, neuropeptide Y, and cortistatin) are markers of GABAergic neurons that specifically target the dendritic compartment of pyramidal cells (de Lecea et al., 1997; Viollet et al., 2008), and that are essential in gating incoming sensory information (Figure 1). The gene discussed is SST; the disease is major depressive disorder.